Daré Bioscience
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $41 | $22 | $9 | $1,807 |
Gross Profit | 41 | -2 | -1 | 1,797 |
EBITDA | -4,671 | -7,344 | -6,011 | -5,047 |
EBIT | -4,681 | -7,359 | -6,022 | -5,057 |
Net Income | -4,702 | 12,910 | -6,755 | -5,057 |
Net Change In Cash | 41 | 22 | 9 | 1,807 |
Free Cash Flow | -5,641 | -6,827 | -6,827 | -8,786 |
Cash | 11,232 | 16,414 | 3,630 | 10,476 |
Basic Shares | 8,534 | 8,476 | 8,376 | 7,295 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,807 | $10,000 | $10,000 | $0 |
Gross Profit | 2,769 | 10,000 | -26 | -43 |
EBITDA | -30,901 | -31,361 | -39,042 | -27,359 |
EBIT | -30,939 | -31,385 | -39,068 | -27,402 |
Net Income | -30,161 | 406,802 | -38,326 | -27,400 |
Net Change In Cash | 2,807 | 10,000 | 10,000 | 0 |
Cost of Revenue | -121 | |||
Free Cash Flow | -39,486 | -18,151 | -28,778 | -25,252 |
Cash | 10,476 | 34,669 | 51,674 | 4,669 |
Basic Shares | 7,275 | 7,047 | 5,096 | 2,507 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.55 |
2024-06-30 | -$0.88 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.06 |
